FDA

News

Interchangeable high-concentration Humira approved in US

For the first time, pharmacists in the US will be able to substitute a cheaper biosimilar version when they receive a prescription for AbbVie’s high-concentration formulat

News

No smartwatch or smart ring can measure blood glucose without a blood sample yet

FDA warns over smartwatches, rings for blood glucose testing

The US FDA has issued a warning against the use of smartwatches or smart ring devices that claim to be able to measure blood glucose levels.

News

United sues FDA to try to block rival’s drug application

In an unusual move, United Therapeutics has filed a lawsuit against the FDA that claims the regulator is sidestepping established norms in allowing rival Liquidia to file

News

Roche’s Xolair is first medicine for food allergy in US

Fast approaching the end of its patent life, Roche and Novartis’ Xolair is going out with a bang, picking up a new approval as the first and only drug therapy for people w

News

Tagrisso-chemo cleared in US as 1st-line lung cancer therapy

AstraZeneca’s Tagrisso can be used alongside chemotherapy as a frontline therapy for EGFR-positive non-small cell lung cancer (NSCLC), according to the FDA, consolidating

News

FDA turns down Satsuma’s nasal migraine treatment

Manufacturing problems have scuppered Satsuma Pharmaceuticals’ chances of a timely FDA approval for its intranasal migraine therapy STS101.

Interchangeable high-concentration Humira approved in US

FDA warns over smartwatches, rings for blood glucose testing

United sues FDA to try to block rival’s drug application

Roche’s Xolair is first medicine for food allergy in US

Tagrisso-chemo cleared in US as 1st-line lung cancer therapy

FDA turns down Satsuma’s nasal migraine treatment

UK issues £45m funding call for research partnerships

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks